Published in
Springer, Breast Cancer Research and Treatment, 2(171), p. 325-334, 2018
DOI: 10.1007/s10549-018-4828-5
Links
Tools
Identification of risk factors for toxicity in patients with hormone receptor-positive advanced breast cancer treated with bevacizumab plus letrozole: a CALGB 40503 (alliance) correlative study
Journal article published in 2018 by
Daneng Li 
,
Linda M. McCall,
Olwen M. Hahn,
Clifford A. Hudis,
Harvey J. Cohen,
Hyman B. Muss,
Aminah Jatoi,
Jacqueline M. Lafky,
Karla V. Ballman,
Eric P. Winer,
Debu Tripathy,
Bryan Schneider,
William Barry,
Maura N. Dickler,
Arti Hurria
,
Linda M. McCall,
Olwen M. Hahn,
Clifford A. Hudis,
Harvey J. Cohen,
Hyman B. Muss,
Aminah Jatoi,
Jacqueline M. Lafky,
Karla V. Ballman,
Eric P. Winer,
Debu Tripathy,
Bryan Schneider,
William Barry,
Maura N. Dickler,
Arti Hurria
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 